Literature DB >> 11298139

Differential requirements for induction of total immunoglobulin and physiological rheumatoid factor production by human peripheral blood B cells.

W J Van Esch1, C C Reparon-Schuijt, E W Levarht, C Van Kooten, F C Breedveld, C L Verweij.   

Abstract

Rheumatoid factors (RFs) are autoantibodies directed against the Fc part of IgG. Considerable evidence exists that there are two classes of RFs, pathological and physiological. Whereas pathological RFs are associated with disease, physiological RFs are considered to be a normal component of the immune response. RF(+) precursor B cells present as part of the B cell repertoire of healthy individuals are held responsible for the production of physiological RFs, which is a transient phenomenon with a clear correlation with an initiating stimulus such as immunization or exposure to an infection. Here we demonstrate a difference in the regulatory control of total Ig and RF production by peripheral blood (PB) B cells of both healthy controls (HC) and patients with rheumatoid arthritis (RA). Highly purified B cells from HC and patients with RA were cocultured with T cells stimulated with immobilized anti-CD3 mAb. Similar to IgM production, IgM-RF production was shown to be dependent on CD40 cross-linking. However, activation of PB B cells in the CD40 system in the presence of IL-2, IL-4, IL-10, combinations of these cytokines or supernatant of anti-CD3-stimulated T cells failed to induce detectable IgM-RF, whereas total IgM production was considerable. From these results we conclude that conditions to activate physiological RF(+) B cells require additional contact besides CD40--CD40L interactions between T and B cells. Since the requirements for RF production were similar using PB B cells from HC and patients with RA it is suggested that the regulatory properties of RF(+) precursors in the PB B cell compartment is equal among these groups. Together, these results indicate that conditions for the induction of total Ig and physiological RFs are different.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11298139      PMCID: PMC1906001          DOI: 10.1046/j.1365-2249.2001.01475.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  49 in total

Review 1.  Understanding the mechanism of action of bacterial superantigens from a decade of research.

Authors:  P M Lavoie; J Thibodeau; F Erard; R P Sékaly
Journal:  Immunol Rev       Date:  1999-04       Impact factor: 12.988

2.  THE OCCURENCE OF RHEUMATOID FACTOR IN ASSOCIATION WITH ANTIBODY RESPONSE TO INFLUENZA A2(ASIAN) VIRUS.

Authors:  K H SVEC; J H DINGLE
Journal:  Arthritis Rheum       Date:  1965-08

3.  The presence of the rheumatoid factor in sera from patients with syphilis.

Authors:  A PELTIER; C L CHRISTIAN
Journal:  Arthritis Rheum       Date:  1959-02

Review 4.  Natural anti-immunoglobulin autoantibodies: irrelevant by-products or immunoregulatory molecules?

Authors:  P Terness; G Opelz
Journal:  Int Arch Allergy Immunol       Date:  1998-04       Impact factor: 2.749

5.  Defective TCR-mediated signaling in synovial T cells in rheumatoid arthritis.

Authors:  M M Maurice; A C Lankester; A C Bezemer; M F Geertsma; P P Tak; F C Breedveld; R A van Lier; C L Verweij
Journal:  J Immunol       Date:  1997-09-15       Impact factor: 5.422

6.  Impaired lymphokine secretion in anergic CD4+ T cells leads to defective help for B cell growth and differentiation.

Authors:  D G Telander; D L Mueller
Journal:  J Immunol       Date:  1997-05-15       Impact factor: 5.422

7.  Unique molecular surface features of in vivo tolerized T cells.

Authors:  C C Maier; A Bhandoola; W Borden; K Yui; K Hayakawa; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

8.  Simultaneous induction of rheumatoid factor- and antigen-specific antibody-secreting cells during the secondary immune response in man.

Authors:  A Tarkowski; C Czerkinsky; L A Nilsson
Journal:  Clin Exp Immunol       Date:  1985-08       Impact factor: 4.330

9.  Functional analysis of rheumatoid factor-producing B cells from the synovial fluid of rheumatoid arthritis patients.

Authors:  C C Reparon-Schuijt; W J van Esch; C van Kooten; E W Levarht; F C Breedveld; C L Verweij
Journal:  Arthritis Rheum       Date:  1998-12

10.  Function of B cells expressing a human immunoglobulin M rheumatoid factor autoantibody in transgenic mice.

Authors:  H Tighe; P P Chen; R Tucker; T J Kipps; J Roudier; F R Jirik; D A Carson
Journal:  J Exp Med       Date:  1993-01-01       Impact factor: 14.307

View more
  5 in total

1.  IgM, IgG, and IgA rheumatoid factors in pigeon hypersensitivity pneumonitis.

Authors:  Mariana Tellez Araiza; Diana E Aguilar León; Virginia Novelo Retana; Erasmo Martínez-Cordero
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

2.  Induction of long-term B-cell depletion in refractory rheumatoid arthritis patients preferentially affects autoreactive more than protective humoral immunity.

Authors:  Y K Onno Teng; Gillian Wheater; Vanessa E Hogan; Philip Stocks; E W Nivine Levarht; Tom W J Huizinga; Rene E M Toes; Jacob M van Laar
Journal:  Arthritis Res Ther       Date:  2012-03-12       Impact factor: 5.156

3.  Rheumatoid Factor: A Novel Determiner in Cancer History.

Authors:  Alessio Ugolini; Marianna Nuti
Journal:  Cancers (Basel)       Date:  2021-02-03       Impact factor: 6.639

4.  Differential responsiveness to immunoablative therapy in refractory rheumatoid arthritis is associated with level and avidity of anti-cyclic citrullinated protein autoantibodies: a case study.

Authors:  Y K Onno Teng; Robert J Verburg; Kirsten N Verpoort; Gwendolyn M P Diepenhorst; Ingeborg M Bajema; Maarten J D van Tol; Els C M Jol-van der Zijde; Rene E M Toes; Tom W J Huizinga; Jacob M van Laar
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

5.  Regulatory and other rheumatoid factors in rheumatoid arthritis patients with active disease or in remission.

Authors:  Liubov Beduleva; Alexandr Sidorov; Kseniya Semenova; Zhanna Khokhlova; Daria Menshikova; Tatyana Khramova; Igor Menshikov
Journal:  J Clin Lab Anal       Date:  2021-12-24       Impact factor: 2.352

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.